Advaxis, Inc. (ADXS) earnings
Quarterly and annual ADXS reports and results, each read against the price at its own news timestamp. Back to the ADXS overview →
5 measured ADXS earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K/A Ayala Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +19.82% | |
| Form 10-K Ayala Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.69% | |
| Form NT 10-K Ayala Pharmaceuticals, For: Apr 01 | SEC filing · Form NT | +0.00% | +0.00% | |
| Form 10-Q Ayala Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form NT 10-Q Ayala Pharmaceuticals, For: Nov 14 | SEC filing · Form NT | +0.00% | -1.24% |
Keep exploring
More ADXS: analyst actions → · SEC filings → · ADXS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) | 49 | -0.01% | 17% |
| Valion Bio, Inc. (VBIO) | 49 | 0.00% | 49% |
| Arch Biopartners Inc (ARCH_CDNX) | 48 | -0.59% | 19% |
| SINO BIOPHARM ORD (SBMFF) | 48 | 0.00% | 4% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.